EGFR and head and neck squamous cell carcinoma: As blockade of EGFR signaling and ICI are the two main targeted treatment approaches in clinical use for HNSCC, we annotated the genes in the network by the gene ontology categories “immune response” (n = 1882) and “EGFR signaling pathway” (n = 123).